bpc-157 clinical trials humans gastrointestinal is being marketed as a “healing peptide” for tendon injuries, joint pain, gut repair, inflammation, and recovery. The problem is that “healing” biology is not always simple in people with cancer BPC-157 Peptide for Healing &

Jas et al., 2015)

A1 receptors activation by adenosine in this type of hyperactive scenario makes it seem like a logical treatment target for seizures

NAD+ levels drop by 10% to 65% as we age, and this varies by organ

Unlike oral supplementswhich must pass through the harsh environment of the digestive tract, often losing up to 80% of their potencyvitamin shots guarantee 100% bioavailability

View the selection of research materials for peptide preparation on the consumables page

From the latest clinical trials shaking up what we thought we knew about glucose metabolism to simple lifestyle tips that make a big difference, its all about staying ahead of the game